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The evidence for using the root of Nauclea latifolia S.M. (Rubiaceae) 
in treating malaria in Africa; and the development of Niprd AM1, as 
an antimalarial phytomedicine from it, are reviewed. This study aimed 
at paving the way for the registration and controlled production of 
Niprd-AM1, which was developed by National Institute for 
Pharmaceutical Research and development (NIPRD), Abuja, Nigeria. 
The study applied official procedures to authenticate and evaluate the 
changes that occur during normal storage in the physicochemical 
variables of the herb and extract. 
The herb contained alkaloids, saponins, terpenoids, but cardiac and 
cyanogenic glycosides and anthraquinones were not detected. Heavy 
metal presence was well below the limits allowed. Most of the quality 
variables evaluated, including TLCs,  remained largely unchanged up 
to the 39 month of storage, but a few began to decline as from the 21st 
month. 
The results are consistent with NIPRD’s intention to regularize the 
production and use of Niprd-AM1 according to good pharmaceutical 
practice (GXP), and suggest that the dried herb and extract are stable 
under tropical room conditions for over a year in sealed glass 
containers.  
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Introduction 
Malaria is a pernicious and pervasive disease 
prevalent in over 100 countries - mainly in 
Africa, Asia and Latin America, but was 
previously rampant in Europe and North 
America, and had been the subject of two Nobel 
Prizes in Medicine: Ross, in 1902 for identifying 
the vector; and Leveran, in 1907 for identifying 
the parasite. Each year over 350 million cases are 
diagnosed, and over 1.5 million die of malaria. 
Three factors account for the threat of this 
scourge especially in developing countries. First, 
the increasing resistance of mosquitoes to 
available insecticides. Second, the increasing 
resistance of parasites to available antimalarials 
[1]. Third, the high cost of effective antimalarials.  
Like in most climes where malaria is endemic, its 
history in Nigeria is both interesting and typical, 
and is here recounted as an illustration.  
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In 1983, malarial mortality in Nigeria was over 
1.5 per 100, 000. In 1987, it was nearly 2 per 100, 
000, then fell steadily to about 1 per 100, 000 in 
1989; and then rose dramatically to about 2 per 
100, 000 in 1990 [2]. It was against this 
background that the Federal Ministry of Health in 
1987 set up the National Malaria Technical 
Committee, led by Professor Ekanem – a 
renowned malariologist, to review the situation 
and initiate moves for the control of the disease in 
Nigeria. The Committee came up with nine 
conclusions that included the following four: 
Plasmodium falciparum was responsible for 90% 
of malarial cases in Nigeria; malaria in Nigeria 
was transmitted by two of the most efficient 
vectors worldwide - Anopheles gambiae and 
Anopheles funestus; malaria in Nigeria, is 
consistently the most prevalent disease, and 
among the top three causes of death; and malaria 
eradication in Nigeria is not feasible in the 
foreseeable future. Although the report 
commented on antimalarial therapies, it 
unfortunately, made no mention of traditional 
herbal remedies, in spite of their wide-spread use 
and claim of effectiveness; and in spite of the fact 
that today’s most celebrated antimalarial – 
artemisinin, resulted from research on Artemisia 
annua - an antimalarial in Chinese herbology.  
As is well known, traditional antimalarials 
abound in West Africa, once called the “White 
man’s grave” because of the toll of malaria on the 
early colonialists. Prominent among these is the 
water extract of the roots of Nauclea latifolia – 
also called African peach. Nauclea latifolia S.M. 
(Rubiaceae) is a perennial tree, widespread in 
most parts of Nigeria. Its medicinal uses, 
especially for malaria, are well known in West 
Africa – for example in Nigeria [3] and Cote 
d’Ivoire [4]. Traditional indications of the plant 
nearly always include malaria, along with other 
infective illnesses. For example, Onyeyili et al [5] 
reported its use as an anthelmintic. The tree bears 
a unique flower consisting of a large reddish 
brown ball with long projecting stamens – for 
which reason it is also called pin cushion tree. It 
fruits late in the rainy season in most of Nigeria. 
Other names by which the plant is known 
include: Nauclea esculenta, Sarcocephalus 
esculentus, and Sarcocephalus latifolius. Most 
notably, Benoit-Vical and others [4] showed that 
the aqueous extract of the stem or root of Nauclea 
latifolia was active against a Colombian, 
chloroquine-resistant strain; and a Nigerian, 
chloroquine-sensitive strain of Plasmodium 
falciparum. The extract had IC50 values similar to 
those of other antimalarial plants - Azadirachta 
indica and Artemisia annua. Also notable, is the 
discovery that strictosamide, which is present in 
the root of Sarcocephalus latifolius is active 
against Plasmodium falciparum [6]. 
When the National Institute for Pharmaceutical 
Research and Development (NIPRD) became 
operational in 1989, one of its earliest drives was 
to develop an antimalarial medicine, which led to 
Niprd-AM1- a phytomedicine developed from the 
root of Nauclea latifolia. A comparative 
randomized clinical trial of Niprd-AM1, 
supported by WHO TDR, was conducted in 
human volunteers, and the phytomedicine was 
found to be superior to a sulphadoxine/ 
pyrimethamine combination, and chloroquine, in 
combating uncomplicated malaria [7].  
 
Experimental 
Treatment and sampling of material 
The roots of Nauclea latifolia (Voucher 
Specimen Number: NIPRD/H/5579) obtained 
during the months of July and October from the 
Institute’s botanical garden and it’s environ were 
air-dried in a well-ventilated shade designed for 
drying medicinal plant materials. The materials 
were subsequently comminuted to coarse powder, 
by first chopping them into bits, followed by 
grinding with mechanized equipment.  The 




The following tests as described by Harborne [9] 
and Onwukaeme and coworkers [10] were carried 
out on the herb or aqueous extract. 
Dragendorff's test for alkaloids 
Dragendorff’s reagent consisting of two 
solutions: Solution A - 1.7 g basic bismuth nitrate 
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in 100 ml water/acetic acid (4:1), and Solution B 
- 40.0 g potassium iodide in 100 ml of water, was 
prepared. The two solutions were mixed as 
follows to yield 100 ml of Dragendorff’s reagent: 
5 ml of Solution A + 5 ml of Solution B + 20 ml 
of acetic acid + 70 ml water. The test was carried 
as follows: About 20 mg of the air-dried herb was 
extracted with 20 ml of methanol by shaking and 
heating over a boiling water bath. The extract was 
subsequently filtered and allowed to cool. Each 2 
ml of the filtrate in a test-tube was treated with 2 
ml of Dragendorff's reagent. The development of 
an orange-brown precipitate presumptively 
indicated the presence of alkaloids. 
 
Frothing test for saponins  
A pinch of the aqueous extract was added to 5 ml 
of water and warmed until dissolved. The 
solution was subsequently shaken vigorously to 
generate froth, and then allowed to stand.  A rich 
froth persisting for 10 minutes indicates the 
presence of saponins. 
 
Salkowaski’s Test for Terpenoids 
To 0.5 g of the herb or 10 mg of the extract was 
added 3 ml of chloroform, mixed thoroughly, and 
filtered.  To 1 ml of the filtrate, 3 ml of 
concentrated sulfuric acid was carefully added to 
form a layer. A reddish brown coloration at the 
interface indicated the presence of terpenoids 
 
Keller-Killani’s Test for Cardiac glycosides 
To 0.5 g of the herb or 10 mg of the extract in a 
tube were added 5 ml of water and 2 ml of glacial 
acetic acid containing one drop of 15 % ferric 
chloride solution. The contents were thoroughly 
mixed, and filtered. Subsequently, 2 ml of the 
filtrate was gently underlayed with 1 ml of 
concentrated sulfuric acid. A brown ring at the 
interface indicated the presence of a deoxysugar 
characteristic of cardenolides. A violet ring may 
appear below the brown ring, while in the acetic 
acid layer a greenish ring may form just above 




Sodium Picrate Paper Test Cyanogenic 
Glycosides 
An aqueous solution of 0.05M picric acid, was 
neutralized with sodium bicarbonate, and filtered.  
Subsequently, a piece of filter paper (5.0 X 
1.5cm) was soaked in the mixture. The paper 
(yellow in color) was dried at room temperature. 
Detection of cyanogenic glycosides: About 0.5 g 
of herb or 10 mg of extract in a tube was 
thoroughly mixed with 5 ml of water and 1 ml of 
chloroform Fresh plant material was cut into 
small pieces and placed in a test tube with The 
tube was stoppered with a cork containing a strip 
of picrate impregnated paper hanging down from 
the stopper, and incubated in hot bath for up to 2 
hours. A change of color from yellow to brown-
red, indicated the release of HCN – hence the 
presence of cyanogenic glycoside. If there was no 
release of HCN within 2 h, indicating a negative 
test, the tube was left at ambient temperature for 
24 and 48 h, so that it could be re-examined. No 
color change after 48 h indicated that the test was 
negative for cyanogenic glycoside 
 
Borntrager's test for anthraquinone 
derivatives 
About 100 mg of air-dried herb was extracted 
with 5 ml of chloroform by shaking and warming 
over a water bath. To about 2 ml of the 
supernatant, 1ml of dilute 10 %v/v ammonia 
solution was added, followed by shaking. A pink 
or red colour in the aqueous layer indicates the 




The following tests, briefly described, were 
carried out on the extracts as per WHO [8]. 
Unless otherwise stated the results are expressed 
as a %w/w of the air-dried sample, and as X ± SD 
(mean ± standard deviation). 
 
Loss on drying  
Drying to constant weight was effected in a 
Lindberg/Blue M gravity-convention oven 
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Total ash and Acid insoluble ash  
 
The materials were placed in a furnace (Vecstar 
Furnace) and heated gradually heated to the 
ignition temperature of 650 - 700 0C.  
Evaluation of water extractive value 
The test utilized ~ 4 g of air-dried and coarsely 
powdered sample, accurately transferred into a 
glass-stoppered, 250-ml reflux conical flask, and 
followed by the addition of 100 ml of water.  
Thin layer chromatography (TLC) 
Florescent, precoated plates were used for both 
the normal and reverse phase TLC. The normal 
phase utilized silica K6, and hexane: ethylacetate: 
methanol (4:4:1) as mobile phase while the 
reverse phase utilized KC18 plate, and methanol: 
water (80:20). The air-dried plate was visualized 
using a viewing cabinet (Cammag) and a UV-
lamp (Cammag – equipped to emit light at 254 or 
366 nm). The resulting chromatogram was 
photographed as shown in the Results.  
 
Assay for metals by atomic absorption 
spectroscopy  
 
The materials and method for atomic absorption 
spectroscopy were as per the British 
Pharmacopoeia as described in detail elsewhere 
[11]. 
 
Determination of bitterness value 
 
Table 1: Phytochemical and TLC Profiles of the herb and extract of Nauclea latifolia  
Normal phase TLC Reverse phase TLC 
The bitterness of the herb was determined by the 
method described by WHO [8] which compare 
the threshold bitter concentration (TBC) of an 
extract of the herb with the TBC of a dilute 
solution of quinine hydrochloride. The bitterness 
value is expressed in units equivalent to the 
bitterness of a solution containing 1 g of quinine 
hydrochloride in 2000 ml. Thus, the bitterness 
value of the solution (1 g of quinine 
Phytochemical 
constituent 
Herb  Extract 
Saponins + + 
Terpenoids  + + 
Alkaloids + + 









Herb (L) and extract (R) in
ethanol developed with
Hexane: Ethyl acetate (4:1)
on K2 normal phase TLC,
and viewed at 366 nm.  
 
The herb yielded 9, while the
extract yielded only 5
principal spots 
Herb (L) and extract (R) in 
ethanol developed with 
Methanol: Water (4:1) on 
KC20 reverse phase TLC, 
and viewed at 366 nm.  
Both the herb and the 
extract yielded 9 principal 
spots. 
 
Footnote to Table 1: (+): Indicates present.  (?): Indicates absent or below detection 
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hydrochloride in 2000 ml of drinking water) is set 
at 2×105 units.  
 
Determination of Foaming Index 
Decoctions of plant materials foam due to the 
presence of saponins. This ability is measured as 
foaming index, and is an important quality 
control parameter. The test was performed by the 
procedure of WHO [8]. The results are expressed 
as a quantity [Q] per ml or as [Q]ml-1.  
 Light absorption and pH of preparations 
Preparations of the plant in water or in methanol 
were appropriately diluted to obtain absorbance 
readings of at least 0.050 at the wavelength 
showing maximum absorption (λmax), using 1-
cm quartz or glass cells and a Jenway or 
Shimadzu UV-VIS Spectrophotometer. In each 
determination, both the dilution factor and the 
absorbance were noted for comparative purposes. 
The acidity or alkalinity of preparations was 
tested by means of a Jenway pH meter, calibrated 
with standard buffer tablets of pH 4, 7 and 10. 
 
Results 
Results on phytochemical and physicochemical 
tests on herb and extract of N. latifolia 
The phytochemical and physicochemical results, 
including TLC and light absorption, are shown in 
Tables 1 and 2. The results provide useful criteria 
for authentication and characterization of the herb 
and the extract. Normal phase TLC indicated 9 
and 5 principal spots for the herb and extract 
respectively; while the reverse phase TLC 
indicated 9 principal spots for both.    
 
Table 2: Results of some physicochemical tests on the 
herb and extract of Nauclea latifolia 
Parameter 

















Loss on drying 
(LOD: % w/w) 
 
9.79 ± 2.00 
(30) 
 
6.50 ± 1.22 (8) 
 
































90 ± 5 (6) 
 
pH of 5 % w/v 
in water 
 
6.4 ± 0.2 
 













(FI: as  ml-1) 
 





A 1%1cm at 




Footnote to Table 2: Footnote to Table 2: The herb 
consists of the bark and woody parts of the root of Nauclea 
latifolia. The extracts were prepared by hot extraction, and 
subsequently evaporated to dryness. The results represent 
Mean ± SD. The TA of the extract was ~ 3x that of the 
herbal drug, but acid insoluble matter was below detection 
in both, suggesting that the herb may have relatively high 
contents of water soluble minerals. The spectra revealed 3 
peaks (at: 688, 454 and 225) and 3 valleys (at: 697, 548 and 
391). The absorption in the visible region (400-600 nm) 
was consistent with the golden yellow color of the extract 
and solution.  
 
Results of metallic contents determinations of 
the herb and extract of N. latifolia 
Table 3 shows that both herb and extract contain 
metallic trace elements, including lead and 
cadmium, but their levels were well below the 
limits allowed in food and drugs, which are: 1.0 
mg/100g for lead; and 0.03 mg/100g for 









Effect of Storage on Quality Variables of the 
Herb and Extract of Nauclea latifolia 
 
Effect of storage on moisture content and 
appearance of herb and extract 
Table 4 shows that the moisture content and the 
appearance of the samples changed significantly 
with storage, for up to 39th month. 
 
Table 4: Effect of storage on moisture content 
and appearance of herb and extract 
__________________________________________________
_________ 




Appearance  Moisture 
(%w/w) 
Appearance 
     
     

































































Footnote to Table 4: The results represent 
(Mean ± SD; n=5-7). Both (a) and (b) indicate that 
the results did not differ significantly from those 
of the 0th month (P > 0.05). 
 
Effect of storage on extractability/ solubility/ 
appearance/ pH of herb and extract  
The Table 5 shows that the extractability of the 
herb, and the appearance and pH of the resulting 
aqueous solution, did not change significantly 
with storage. Similarly, the solubility of the dry 
extract, and the appearance and pH of the 
resulting aqueous solution did not change 
significantly with storage, for up to 39th month.  
 
Table 5: Effect of storage on extractability/ solubility/ 















































Na K Ca Mg Mn Fe Cu Zn Cd Pb Se Cr 
Herb 3.2 6.4 200 297 0.81 0.37 1.80 0.79 < 
0.01 
< 0.1 4.1 0.16 
Extract 6.1 2.3 54 260 0.79 0.10 1.18 0.65 < 
0.01 
< 0.1 2.4 0.47 
 
Footnote to Table 3: The results are consistent with the inference that the TAs of the samples are mainly physiological ash, 
because: even though the TA of the herb (3.09 ± 1.28) was lower than that of the extract (9.88 ± 2.60), the extract generally 
contained less of each metal per unit weight.  Apart from Na and Cr whose levels were higher in the extract, the level of every 
other metal was higher in the herb, suggesting that only a fraction of their salts were extracted with water. The TA results for the 
herb are, of course, independent of extractability. Apart from lead oxide, the oxides of all the other metals above are soluble in 
the 2M HCl or (70g/l) used in the determination of acid insoluble ash. The levels of Cd and Pb were the lowest - occurring 
below the allowed limits of 0.3mg/100g for Cd; and10 mg/100g for Pb. The levels of Ca and Mg, on the other hand, were the 
highest, ranging from 53.9 to 297.3 mg/100g. 
















































Footnote to Table 5: The results represent (Mean ± SD; 
n=5-7). The notation (a), (b), (c) and (d) indicate that the 
results did not differ statistically from those of 0th month (P 
> 0.05). 
 
Effect of storage on light absorption and TLC 
features of the herb and extract 
Table 6 shows that storage had no significant 
effect on light absorption and the TLC 
characteristics of the samples. But it is 
remarkable that the reverse phase TLC of the 
extract revealed 5 principal spots, while of that of 
the herb revealed 9 spots. This suggests that the 
extract may be deficient in some constituents – 
owing to their being less water soluble. 
 
Table 6: Effect of storage on light absorption and 
TLC features of the herb and extract 
 
Herb Extract 
Nos. TLC  
spots 


















0 2.048 ± 
0.028 









9 9 2.031 ± 
0.024 
5 9 




9 9 2.041 ± 
0.034 
5 9 



















Footnote to Table 6: The solutions of herb and 
extract were made by thoroughly mixing 1 part of  
solute and with 100 parts of solvent (MeOH: H₂O 
[50:50, v/v]), filtering, and diluting the filtrates 
by 25x (herb) or 125 x (extract) with the same 
solvent. Absorbencies were measured at λ225 
nm, using the solvent as the blank.  The results 
represent (Mean ± SD; n=5-7). Both (a) and (b) 
denote that the results did not differ significantly 
from those of the 0th month (P > 0.05). Both the 
normal and reverse TLCs of the herb gave 9 
spots, but the corresponding TLCs for the extract 
were 5 and 9.  
 
Effect of storage on the bitterness values and 
foaming indices of herb and extract 
Table 7 shows that the bitterness value and 
foaming index of the herb did not change 
significantly with storage up to 39th month. By 
contrast, the corresponding results for the extract 
decreased significantly from the 21st week of 
storage. These results in combination with the 
TLC results above may suggest the superiority of 
the dry herb over the dry water extract. 
 
Table 7: Effect of storage on the bitterness values and foaming 
indices of herb and extract 
 
































3 0.57 ± 
0.07
 a













9 0.58 ± 
0.07
 a
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Footnote to Table 7: The results represent (Mean ± SD). The 
notations (a) and (c) imply that the results did not differ significant 
from those of the 0th month (P > 0.05). By contrast (b) and (d) 
imply that the results for the 21st / 39th months were significantly 
lower than those of preceding months (P < 0.05).  
 
Discussion 
Studies at NIPRD on Nauclea latifolia and Niprd 
AM1 since the 1990’s had confirmed the efficacy 
and safety of Niprd AM1. Under Professor 
Gamaniel, the department of Pharmacology had 
confirmed the efficacy and safety profile of Niprd 
AM 1 in mice infected with Plasmodium berghei; 
found the LD50 in mice and rats to be over 
2000mg/kg per oral; and confirmed the efficacy 
and superiority of Niprd AM1 over standard 
antimalarial therapies in human clinical trials [7]. 
The drug Niprd AM1, administered as capsules in 
the trial, was prepared in the department of 
Pharmaceutical Technology, under Professors 
Nasipuri and Kunle, who confirmed that the 
herbal substance had the following features: bulk 
density, 0.1435 g/ml; tapped density, 0.1786 
g/ml; true density, 3.0345 g/ml; and hydration 
value, 3.8833 units. However, GMP production 
requires also that the keeping qualities of the herb 
and extract be assured. Thus, this study was 
prompted by the need to assess the real time 
stability of these materials.  
The herbal substance of Niprd AM1 is here 
defined as the dry water extract of the coarsely 
comminuted fragments of the root of Nauclea 
latifolia, which consists of a thick, dark brown 
bark and a yellow woody core. The parts are 
odourless or faintly aromatic. The taste is 
excitingly bitter – more like the taste niacinamide 
rather than quinine. Botanical studies in NIPRD’s 
department of Medicinal Plant Research and 
Traditional Medicine revealed the following, on 
the root of N. latifolia: the bark consists of 
exfoliated, slightly lignified, roughly striated, thin 
walled polygonal cork cells. The cortex contains 
layers of oblong parenchymatous cells, oil 
globules, and sclereids occurring singly or in 
groups, and possessing a constricted lumen. The 
phloem consists of lignified fibres, interrupted by 
radially packed medullary rays and starch-laden 
parenchymatous cells. The xylem consists of 
large and small vessels composed of tubular cells 
bearing yellowish grains. A key step in a 
controlled production of Niprd AM1 would 
ensure that the vegetal raw material to be used 
has the above botanical features. Thus, in 
consonance with good manufacturing practice 
(GMP), any portion of the root system lacking 
these features, and those described in Tables 1-3, 
are to be excluded in the production of the Niprd 
AM1.  
Another important consideration in GMP 
production is the need for assurance that the 
vegetal matter used in production has adequate 
keeping qualities, since the herb is mostly not 
used immediately. Indeed, the practice among 
traditional healers is to have the dry herb in their 
apothecary in readiness for when decoctions are 
required. Usually the healers have the well dried 
herb neatly wrapped up in cellophane bags, or 
stored away in covered plastic containers. The 
materials may remain in this condition some 
times for over a year or season before they are 
consumed or discarded. The question that arises 
is: For how long can the dried herb or the extract 
be kept without significant deterioration? The 
results in Tables 4-7 provide an attempt to answer 
this important question, both from the point of 
view of traditional usage and the intention by 
NIPRD to optimize that usage. The results 
collectively prove that when the dry herb and the 
dry water extract of the root of Nauclea latifolia 
are stored away from light under tropical room 
conditions, the quality variables evaluated do not 
change significantly for up to 39 months for the 
herb and 21 months extract. For extract (not the 
herb) the bitterness value and foaming index fell 
slightly but significantly as from the 21st month 
of storage. This defect and the fact the normal 
phase TLC of the extract yielded only 5 instead 
of the 9 principal spots yielded by the herb, 
should be taken note of in further development 
work on Niprd AM1. 
 
Conclusion 
The results of this study establish that the herb 
and the dry water extract of the root of Nauclea 
latifolia are stable for at least a year and a half 
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even in tropical conditions. The results are 
consistent with the practice of traditional healers 
in West Africa who use the dry herb for 
antimalarial therapy even after a year or two of 
storage in their apothecaries. 
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